Lisa S Letellier, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 |
Zhenxiong Zhang, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 544 Campbell Ave, West Haven, CT 06516 Phone: 203-937-6150 Fax: 203-937-8517 |
Dr. Angela Helen Ryan, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Cellini Pl Ste 102, West Haven, CT 06516 Phone: 203-932-6481 |
News Archive
A longitudinal study of children of parents with bipolar disorder gives insights into the developmental trajectory of the condition, which researchers say should prove valuable in guiding future intervention and prevention efforts.
Two symposia focusing on the ecological dynamics of infectious diseases such as avian influenza, Yellow Fever, and Lyme will take place during the Ecological Society of America's 98th Annual Meeting, held this year in Minneapolis, Minnesota.
In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis (CF). There were no discontinuations due to adverse events in the study, and the frequency of adverse events was similar across the study groups.
Washington State University researchers have discovered a way to help cancer cells age and die, creating a promising avenue for slowing and even stopping the growth of tumors. "Hopefully, we can make cancer cells die like normal cells," says Weihang Chai, an assistant professor in the WSU School of Molecular Biosciences and WWAMI medical education program in Spokane. "Basically, you make the cancer cell go from immortal to mortal."
Democrats are looking at proposals to crack down on licensing agreements between drug companies that keep generic drugs out of the market, Politico reports. In the agreements, pharmaceutical companies pay generic manufacturers to "delay introduction of generic drugs, which are often cheaper than brand-name drugs.
› Verified 3 days ago